Skip to content
  • Sunday, 26 July 2026
  • 1:45 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The Moderate Caffeine Advantage: Long-Term Study Links Daily Coffee Consumption to a Reduced Risk of Dementia and Cognitive Decline
Neuroscience & Brain Research

The Moderate Caffeine Advantage: Long-Term Study Links Daily Coffee Consumption to a Reduced Risk of Dementia and Cognitive Decline

Rifan Muazin May 19, 2026 0

Recent longitudinal research published in JAMA Network Open has provided some of the most compelling evidence to date regarding the…

Read More
Environmental & Analytical Chemistry

A New Equation Quantifies the Perfect Espresso Shot by Understanding Coffee Puck Permeability

Abdurrohim Arsyad Apr 25, 2026 0

A groundbreaking study published in the April 1st issue of Royal Society Open Science has introduced a novel equation designed…

Read More
Neuroscience & Brain Research

Long-Term Caffeinated Coffee and Tea Consumption Linked to Reduced Dementia Risk and Better Cognitive Preservation in Large Scale Prospective Study

Rifan Muazin Apr 4, 2026 0

A landmark longitudinal study involving over 130,000 participants has identified a significant correlation between the regular consumption of caffeinated beverages…

Read More
Neuroscience & Brain Research

Long-Term Harvard Study Identifies Link Between Caffeinated Coffee and Tea Consumption and Reduced Risk of Dementia and Cognitive Decline

Rifan Muazin Mar 26, 2026 0

In a landmark investigation spanning four decades, researchers from Mass General Brigham, the Harvard T.H. Chan School of Public Health,…

Read More
Neuroscience & Brain Research

Moderate Consumption of Caffeinated Coffee and Tea Associated with Reduced Risk of Dementia and Slower Cognitive Decline Over Four Decades

Rifan Muazin Mar 18, 2026 0

In a comprehensive longitudinal analysis that spans more than 40 years of clinical observation, researchers from Mass General Brigham, the…

Read More
Cerebrovascular Function and Oxygen Regulation as Early Biomarkers for Alzheimer’s Disease Risk and Cognitive Decline10 GitHub Repositories to Master Self-Hosting: A Comprehensive Guide to Decentralized InfrastructureTWiV 1285: Encapsidating Viruses 2025Record-Breaking 220 PeV Cosmic Neutrino Detection Points to Blazars as Supreme Galactic Accelerators
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ